Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib dose comparison and gene identification in primary hypertrophic osteoarthropathy
ChiCTR2400088281Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of etoricoxib in Pachydermoperiostosis (PDP) (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: percentage of symptom relief and Suspected gene mutation. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
Pachydermoperiostosis (PDP)
Beyond the preview
Go deeper on ChiCTR2400088281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088281.